Bigfoot Biomedical, Milpitas, California
Bryan Mazlish, Bigfoot Biomedical co-founder and Chief Product Officer, previously led a successful career in quantitative finance, first as management in one of the world’s largest securities trading institutions, and subsequently as an entrepreneur, where he founded and led a fully automated trading company. Since his son’s diagnosis with Type 1 Diabetes (T1D) in 2011, Bryan has focused his efforts in the diabetes technology space where he invented algorithms for predicting glucose values and automating insulin delivery. His wife and son, both of whom have T1D, have benefited for over five years from the use of a proof of concept device that he created to automate their insulin delivery - the first real world demonstration of successful use of adaptive insulin delivery algorithms in pediatric and adult settings over an extended period of time. This work led to his co-founding Bigfoot Biomedical in 2014, a Silicon Valley startup dedicated to developing technologies that significantly reduce the cognitive, emotional, and financial burdens of insulin-requiring diabetes.